New Findings Reported from King Saud University Describe Advances in Alzheimer Disease (Public Willingness to Undergo Presymptomatic Genetic Testing for Alzheimer’s Disease)

2019 APR 17 (NewsRx) -- By a News Reporter-Staff News Editor at Middle East Daily -- Investigators publish new report on Neurodegenerative Diseases and Conditions - Alzheimer Disease. According to news reporting originating from Riyadh, Saudi Arabia, by NewsRx correspondents, research stated, “Presymptomatic genetic testing (PGT) for Alzheimer’s disease (AD) is available for at-risk individuals. This study aimed to investigate the public perception of PGT in Saudi Arabia and determine variables that might influence the decision to undergo PGT.”

Financial support for this research came from King Saud University.

Our news editors obtained a quote from the research from King Saud University, “A questionnaire link was posted on Twitter by the Saudi Alzheimer’s Disease Association and was made publicly available on social media networks. A total of 2935 people participated, of which 59.9% were willing to undergo PGT. Of these, 26.8% reported having a family history of AD, and 0.24% had two family members with early onset AD. The reasons cited for willingness to undergo PGT included the following: to adopt a healthier lifestyle, to ensure appropriate family and financial planning, to seek early treatment, and to relieve anxiety. In multiple logistic regression analysis, willingness to undergo PGT was negatively associated with having a self-reported family history of dementia (OR 0.81, 95% CI 0.68-0.96) and was positively associated with marital status (OR 1.39, 95% CI 1.13-1.70).”

According to the news editors, the research concluded: “PGT for AD seems to be well accepted in this large Saudi cohort. The reasons cited are similar to those reported elsewhere in the literature.”

For more information on this research see: Public Willingness to Undergo Presymptomatic Genetic Testing for Alzheimer’s Disease. Neurology Research International, 2019;2019():1-6. (Hindawi Publishing - www.hindawi.com; Neurology Research International - http://www.hindawi.com/journals/nri/)

The news editors report that additional information may be obtained by contacting M.H. Alanazy, Division of Neurology, Dept. of Internal Medicine, King Saud University Medical City and College of Medicine, King Saud University, Riyadh, Saudi Arabia. Additional authors for this research include K.A. Alghsoon, A.F. Alkhodairi, F.K. Binkhonain, T.N. Alsehli, F.F. Altukhaim, I.M. Alkhodair and T. Muayqil.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1155/2019/2570513. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)